LifeMD, Inc.
LFMD
$6.14
-$0.16-2.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.30% | 2.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.30% | 2.25% | |||
| Cost of Revenue | -14.03% | -8.34% | |||
| Gross Profit | -3.97% | 4.07% | |||
| SG&A Expenses | 1.21% | 1.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 24.43% | -10.33% | |||
| Total Operating Expenses | -0.05% | -0.13% | |||
| Operating Income | -135.66% | 149.74% | |||
| Income Before Tax | -181.91% | 374.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -181.91% | 716.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 5.02% | -55.95% | |||
| Net Income | -249.83% | 1,402.73% | |||
| EBIT | -135.66% | 149.74% | |||
| EBITDA | -115.63% | 106.42% | |||
| EPS Basic | -555.32% | 167.46% | |||
| Normalized Basic EPS | -317.53% | 833.33% | |||
| EPS Diluted | -742.00% | 147.85% | |||
| Normalized Diluted EPS | -329.45% | 795.24% | |||
| Average Basic Shares Outstanding | 2.93% | 2.20% | |||
| Average Diluted Shares Outstanding | -2.59% | 8.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.67% | 1.08% | |||